Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from BioGaia AB submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EFSA J
Main Authors: Turck, Dominique, Castenmiller, Jacqueline, De Henauw, Stefaan, Ildico Hirsch‐Ernst, Karen, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Bresson, Jean‐Louis, Sanz, Yolanda, Siani, Alfonso
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Scientific Opinion
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447865/
https://ncbi.nlm.nih.gov/pubmed/32874242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2020.6004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares